Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
暂无分享，去创建一个
A. Tafreshi | J. Carles | S. Oudard | G. Gravis | E. Yu | T. Todenhöfer | J. D. de Bono | C. Massard | J. Piulats | P. Fong | H. Gurney | C. Poehlein | B. Laguerre | J. Arranz | M. Kolinsky | J. Heinzelbecker | L. Nordquist | C. Schloss | M. Augustin | P. Qiu | X. Li